{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:30:23Z","timestamp":1791343823535,"version":"4.3.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["PO 681\/5-2"],"award-info":[{"award-number":["PO 681\/5-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Community's Seventh Framework Program","award":["201380"],"award-info":[{"award-number":["201380"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.neuropharm.2014.05.002","type":"journal-article","created":{"date-parts":[[2014,5,28]],"date-time":"2014-05-28T15:16:08Z","timestamp":1401290168000},"page":"104-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["(R)-[11C]PK11195 brain uptake as a biomarker of inflammation and antiepileptic drug resistance: Evaluation in a rat epilepsy model"],"prefix":"10.1016","volume":"85","author":[{"given":"Ren\u00e9e Marie","family":"Bogdanovi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stina","family":"Syv\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Michler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Russmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert D.","family":"Windhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriaan A.","family":"Lammertsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth C.","family":"de Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob A.","family":"Voskuyl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidrun","family":"Potschka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl.\u00a03","key":"10.1016\/j.neuropharm.2014.05.002_bib1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1528-1167.2011.03033.x","article-title":"Inflammation in epilepsy: clinical observations","volume":"52","author":"Aronica","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2014.05.002_bib2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.neuroscience.2009.03.005","article-title":"Molecular and functional interactions between tumor necrosis factor-alpha receptors and the glutamatergic system in the mouse hippocampus: implications for seizure susceptibility","volume":"161","author":"Balosso","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2014.05.002_bib3","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1212\/WNL.53.9.2199","article-title":"[11C](R)-PK11195 positron emission tomography imaging of activated microglia in\u00a0vivo in Rasmussen's encephalitis","volume":"53","author":"Banati","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2014.05.002_bib4","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1111\/j.1528-1167.2010.02671.x","article-title":"Imaging of P-glycoprotein-mediated pharmacoresistance in the hippocampus: proof-of-concept in a chronic rat model of temporal lobe epilepsy","volume":"51","author":"Bartmann","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2014.05.002_bib5","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1124\/mol.107.041210","article-title":"Seizure-induced up-regulation of P-glycoprotein at the blood-brain barrier through glutamate and cyclooxygenase-2 signaling","volume":"73","author":"Bauer","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.05.002_bib6","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1528-1167.2007.00980.x","article-title":"Resistance to phenobarbital extends to phenytoin in a rat model of temporal lobe epilepsy","volume":"48","author":"Bethmann","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2014.05.002_bib7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0920-1211(03)00114-1","article-title":"Epileptogenesis and neuropathology after different types of status epilepticus induced by prolonged electrical stimulation of the basolateral amygdala in rats","volume":"55","author":"Brandt","year":"2003","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2014.05.002_bib8","doi-asserted-by":"crossref","first-page":"580717","DOI":"10.1155\/2012\/580717","article-title":"Reproducible analysis of rat brain PET studies using an additional [(18)F]NaF scan and an MR-based ROI template","volume":"2012","author":"Buiter","year":"2012","journal-title":"Int. J. Mol. Imaging"},{"key":"10.1016\/j.neuropharm.2014.05.002_bib9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1552-6569.2010.00572.x","article-title":"Imaging inflammation in a patient with epilepsy due to focal cortical dysplasia","volume":"23","author":"Butler","year":"2013","journal-title":"J.\u00a0Neuroimaging"},{"key":"10.1016\/j.neuropharm.2014.05.002_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(90)91054-K","article-title":"Progressive neuronal loss induced by kindling: a possible mechanism for mossy fiber synaptic reorganization and hippocampal sclerosis","volume":"527","author":"Cavazos","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2014.05.002_bib11","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1088\/0031-9155\/52\/5\/019","article-title":"Performance evaluation of the ECAT HRRT: an LSO-LYSO double layer high resolution, high sensitivity scanner","volume":"52","author":"de Jong","year":"2007","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.neuropharm.2014.05.002_bib12","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/2191-219X-2-60","article-title":"PET imaging of brain inflammation during early epileptogenesis in a rat model of temporal lobe epilepsy","volume":"2","author":"Dedeurwaerdere","year":"2012","journal-title":"EJNMMI Res."},{"key":"10.1016\/j.neuropharm.2014.05.002_bib13","doi-asserted-by":"crossref","first-page":"466","DOI":"10.2967\/jnumed.113.125625","article-title":"Detection of microglial activation in an acute model of neuroinflammation using PET and radiotracers 11C-(R)-PK11195 and 18F-GE-180","volume":"55","author":"Dickens","year":"2014","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.neuropharm.2014.05.002_bib14","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1046\/j.1528-1157.2002.18101.x","article-title":"Effects of the novel antiepileptic drug levetiracetam on spontaneous recurrent seizures in the rat pilocarpine model of temporal lobe epilepsy","volume":"43","author":"Glien","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2014.05.002_bib15","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1093\/brain\/awn265","article-title":"Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology","volume":"131","author":"Gouw","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2014.05.002_bib16","doi-asserted-by":"crossref","first-page":"234","DOI":"10.2967\/jnumed.111.091694","article-title":"Increased in\u00a0vivo expression of an inflammatory marker in temporal lobe epilepsy","volume":"53","author":"Hirvonen","year":"2012","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.neuropharm.2014.05.002_bib17","first-page":"81","article-title":"In\u00a0vivo evaluation of P-glycoprotein modulation of 8 PET radioligands used clinically","volume":"48","author":"Ishiwata","year":"2007","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.neuropharm.2014.05.002_bib18","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1177\/0883073809338063","article-title":"Positron emission tomography imaging of neuroinflammation","volume":"24","author":"Kannan","year":"2009","journal-title":"J.\u00a0Child. Neurol."},{"key":"10.1016\/j.neuropharm.2014.05.002_bib19","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1528-1157.1992.tb02336.x","article-title":"In\u00a0vitro quantitative autoradiography of [3H]-L-deprenyl and [3H]-PK 11195 binding sites in human epileptic hippocampus","volume":"33","author":"Kumlien","year":"1992","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2014.05.002_bib20","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1742-2094-4-4","article-title":"Microglia activation in sepsis: a case-control study","volume":"4","author":"Lemstra","year":"2007","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2014.05.002_bib21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1162\/153535003322556877","article-title":"AMIDE: a free software tool for multimodality medical image analysis","volume":"2","author":"Loening","year":"2003","journal-title":"Mol. Imaging"},{"key":"10.1016\/j.neuropharm.2014.05.002_bib22","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1124\/pr.110.003046","article-title":"Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research","volume":"62","author":"Loscher","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2014.05.002_bib23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.tins.2013.11.002","article-title":"Inflammatory pathways of seizure disorders","volume":"37","author":"Marchi","year":"2014","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2014.05.002_bib24","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1365-2796.2011.02431.x","article-title":"Interleukin-1 type 1 receptor\/Toll-like receptor signalling in epilepsy: the importance of IL-1beta and high-mobility group box 1","volume":"270","author":"Maroso","year":"2011","journal-title":"J.\u00a0Intern. Med."},{"key":"10.1016\/j.neuropharm.2014.05.002_bib25","series-title":"The Rat Brain in Stereotactic Coordinates","author":"Paxinos","year":"1998"},{"key":"10.1016\/j.neuropharm.2014.05.002_bib26","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1471-4159.2007.05172.x","article-title":"Targeting epileptogenesis-associated induction of neurogenesis by enzymatic depolysialylation of NCAM counteracts spatial learning dysfunction but fails to impact epilepsy development","volume":"105","author":"Pekcec","year":"2008","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2014.05.002_bib27","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/WNR.0b013e3280b07b8d","article-title":"Newborn neurons with hilar basal dendrites hallmark epileptogenic networks","volume":"18","author":"Pekcec","year":"2007","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2014.05.002_bib28","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1528-1167.2010.02585.x","article-title":"Modulating P-glycoprotein regulation: future perspectives for pharmacoresistant epilepsies?","volume":"51","author":"Potschka","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2014.05.002_bib29","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1684\/epd.2012.0532","article-title":"Animal models of drug-resistant epilepsy","volume":"14","author":"Potschka","year":"2012","journal-title":"Epileptic Disord."},{"key":"10.1016\/j.neuropharm.2014.05.002_bib30","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.addr.2011.12.007","article-title":"Role of CNS efflux drug transporters in antiepileptic drug delivery: overcoming CNS efflux drug transport","volume":"64","author":"Potschka","year":"2012","journal-title":"Adv. Drug. Deliv. Rev."},{"issue":"Suppl.\u00a02","key":"10.1016\/j.neuropharm.2014.05.002_bib31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/epi.12181","article-title":"Animal and human data: where are our concepts for drug-resistant epilepsy going?","volume":"54","author":"Potschka","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2014.05.002_bib32","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","article-title":"Modification of seizure activity by electrical stimulation. II. Motor seizure","volume":"32","author":"Racine","year":"1972","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2014.05.002_bib33","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1535-7511.2008.00272.x","article-title":"Intrinsic severity as a determinant of antiepileptic drug refractoriness","volume":"8","author":"Rogawski","year":"2008","journal-title":"Epilepsy Curr."},{"key":"10.1016\/j.neuropharm.2014.05.002_bib34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1023\/A:1014044128845","article-title":"Increased expression of \u201cperipheral-type\u201d benzodiazepine receptors in human temporal lobe epilepsy: implications for PET imaging of hippocampal sclerosis","volume":"17","author":"Sauvageau","year":"2002","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neuropharm.2014.05.002_bib35","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1476-5381.2010.00765.x","article-title":"Celecoxib treatment restores pharmacosensitivity in a rat model of pharmacoresistant epilepsy","volume":"160","author":"Schlichtiger","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.05.002_bib36","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1111\/j.1528-1167.2011.03302.x","article-title":"The erythropoietin-derived peptide mimetic pHBSP affects cellular and cognitive consequences in a rat post-status epilepticus model","volume":"52","author":"Seeger","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2014.05.002_bib37","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0969-8051(94)90022-1","article-title":"Synthesis of the enantiomers of [N-methyl-11C]PK 11195 and comparison of their behaviours as radioligands for PK binding sites in rats","volume":"21","author":"Shah","year":"1994","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.neuropharm.2014.05.002_bib38","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2967\/jnumed.110.079608","article-title":"Transport of selected PET radiotracers by human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2): an in\u00a0vitro screening","volume":"52","author":"Tournier","year":"2011","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.neuropharm.2014.05.002_bib39","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2967\/jnumed.108.058628","article-title":"HRRT versus HR+ human brain PET studies: an interscanner test-retest study","volume":"50","author":"van Velden","year":"2009","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.neuropharm.2014.05.002_bib40","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.neuropharm.2009.09.012","article-title":"COX-2 inhibition controls P-glycoprotein expression and promotes brain delivery of phenytoin in chronic epileptic rats","volume":"58","author":"van Vliet","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2014.05.002_bib41","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/glia.22357","article-title":"Molecular imaging of microglia\/macrophages in the brain","volume":"61","author":"Venneti","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2014.05.002_bib42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.expneurol.2011.09.033","article-title":"Epilepsy and brain inflammation","volume":"244","author":"Vezzani","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2014.05.002_bib43","series-title":"Jasper's Basic Mechanisms of the Epilepsies","article-title":"Glia-neuronal interactions in ictogenesis and epileptogenesis: role of inflammatory mediators","author":"Vezzani","year":"2012"},{"key":"10.1016\/j.neuropharm.2014.05.002_bib44","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.bbi.2008.03.009","article-title":"The role of cytokines in the pathophysiology of epilepsy","volume":"22","author":"Vezzani","year":"2008","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2014.05.002_bib45","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.nbd.2005.09.006","article-title":"Antiepileptic drug-resistant rats differ from drug-responsive rats in hippocampal neurodegeneration and GABA(A) receptor ligand binding in a model of temporal lobe epilepsy","volume":"21","author":"Volk","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2014.05.002_bib46","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/brain\/awh437","article-title":"Multidrug resistance in epilepsy: rats with drug-resistant seizures exhibit enhanced brain expression of P-glycoprotein compared with rats with drug-responsive seizures","volume":"128","author":"Volk","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2014.05.002_bib47","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.neuropharm.2009.01.009","article-title":"Prevention of seizure-induced up-regulation of endothelial P-glycoprotein by COX-2 inhibition","volume":"56","author":"Zibell","year":"2009","journal-title":"Neuropharmacology"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390814001695?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390814001695?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T07:57:17Z","timestamp":1597910237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390814001695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":47,"alternative-id":["S0028390814001695"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2014.05.002","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"(R)-[11C]PK11195 brain uptake as a biomarker of inflammation and antiepileptic drug resistance: Evaluation in a rat epilepsy model","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2014.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}